Based on Imperacer® Chimera Biotec develops and markets ultra-sensitive ligand-binding assays for pharmacokinetic, pharmacodynamic and biomarker applications. Imperacer® quantitatively detects molecules such as proteins, peptides, biomarkers and metabolites in complex biological samples while extending the dynamic range of any immunoassay by orders of magnitude.
Chimera Biotec has over 10 years of in-depth experience as specialty CRO for immunoassays. Based on Imperacer®, Chimera Biotec develops and markets ultra-sensitive ligand-binding assays for pharmacokinetic, pharmacodynamic and biomarker applications. Imperacer® combines unmet specificity of ELISA-type ligand-binding assay technology with the most sensitive detection system known in molecular biology, an real-time PCR read-out.
Imperacer® is the most sensitive immunoassay system on the market, with sensitivities on average 1000-fold better than classical techniques. Chimera Biotec offers Imperacer® assay setup and method development services as well as downstream bioanalytical sample testing support to meet most challenging demands in immunoanalytics. Imperacer® services are conducted under strict quality regime and bioanalytical sample testing is available for all needed regulatory demands, up to full GLP-compliant support.
Chimera Biotec also offers of the shelf products for the in-house development of ultra-sensitive methods using the Imperacer® assay development kit in combination with the matching laboratory equipment provided with the Imperacer® Workstation. A multitude of case studies and peer-reviewed publications is available upon request. Please feel free to contact Chimera Biotec’s team of dedicated scientists at your convenience. We are looking forward to provide you with the immunoassay to exceed your highest expectations.